Things to know when you get cancer

You can get faster answers and potentially better care by prioritizing top-ranked cancer centers over local options.

The author, diagnosed with squamous cell carcinoma in May 2026, shares personal insights for others facing a cancer diagnosis. Key advice includes being persistent in scheduling appointments, as cancellations can lead to earlier access. The author notes that AI models may downplay the seriousness of symptoms, advising users to consult human medical professionals. Pushing for comprehensive genetic testing is crucial, as initial referrals or testing processes can cause delays. The author emphasizes the patient's role in taking control of their case, researching "Standard of Care" guidelines (like NCCN), and using AI to navigate treatment options. Seeking advice from individuals who have undergone similar surgeries and asking surgeons about their experience and complication rates is recommended. Obtaining a second opinion at a major cancer center, potentially involving travel, is advised for a thorough review of the diagnosis and pathology. The author also suggests using AI to summarize medical notes and track progress, and highlights resources like the Sijbrandij Foundation for additional support and guidance. Proximity to major cancer centers can significantly expedite answers and care compared to local hospitals.

The author's experience underscores a growing gap between readily available AI information and the complex, urgent needs of patients facing serious diagnoses. While AI can offer summaries, it appears to struggle with nuanced medical advice and potentially risks downplaying critical symptoms. This suggests a need for more specialized AI development or clear user education on AI's limitations in healthcare, especially for emergent conditions. The reliance on AI for navigating complex treatment pathways also highlights the potential for AI to become an indispensable tool for patients, provided it is used critically and in conjunction with expert medical opinions.

The article points to a systemic issue in healthcare access and information flow, particularly concerning specialized treatments like genetic testing and second opinions. The author's proactive approach, involving persistent follow-ups, self-directed research using NCCN guidelines, and seeking out specialized centers, suggests that patient advocacy is paramount. The efficiency gains observed at major cancer centers, stemming from established networks and direct access to specialists, contrast sharply with potential delays in community hospitals. This highlights the competitive advantage of top-tier medical institutions and the strategic importance for patients to actively navigate towards them.